A. Lambiase
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging top 10%
- Immunology
- Co-authors
- Claudio BordignonVanesa GregorcGiovanni CitterioArmando SantoroFederico Caligaris‐CappioGilda RossoniLuigi MarianiEmilio Bajetta
- Topics
- Peptidase Inhibition and Analysis (32 papers)Lung Cancer Research Studies (21 papers)Neuroendocrine Tumor Research Advances (20 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
A. Lambiase
54 papers receiving 871 citations
Peers
Comparison fields: 5 of 62
- Oncology 613
- Molecular Biology 297
- Pulmonary and Respiratory Medicine 181
- Radiology, Nuclear Medicine and Imaging 146
- Immunology 102
Countries citing papers authored by A. Lambiase
This map shows the geographic impact of A. Lambiase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lambiase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lambiase more than expected).
Fields of papers citing papers by A. Lambiase
This network shows the impact of papers produced by A. Lambiase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lambiase. The network helps show where A. Lambiase may publish in the future.
Co-authorship network of co-authors of A. Lambiase
This figure shows the co-authorship network connecting the top 25 collaborators of A. Lambiase. A scholar is included among the top collaborators of A. Lambiase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lambiase. A. Lambiase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 55 | |
| 2 | 2 | |
| 3 | 36 | |
| 4 | 2 | |
| 5 | 19 | |
| 6 | 40 | |
| 7 | 4 | |
| 8 | 16 | |
| 9 | 29 | |
| 10 | 47 | |
| 11 | 71 | |
| 12 | 107 | |
| 13 | 20 | |
| 14 | 115 | |
| 15 | 17 | |
| 16 | 0 | |
| 17 | 18 | |
| 18 | Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer a multicenter phase II study | 5 |
| 19 | 4 | |
| 20 | Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study | 8 |
About A. Lambiase
A. Lambiase is a scholar working on Oncology, Epidemiology and Biotechnology, having authored 55 papers that have together received 899 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (32 papers), Lung Cancer Research Studies (21 papers) and Neuroendocrine Tumor Research Advances (20 papers). The work is most often cited by research in Oncology (613 citations), Hepatology (67 citations) and Radiology, Nuclear Medicine and Imaging (146 citations). A. Lambiase has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Claudio Bordignon, Vanesa Gregorc, Giovanni Citterio, Armando Santoro, Federico Caligaris‐Cappio, Gilda Rossoni, Luigi Mariani, Emilio Bajetta, Johanna N.H. Timmer-Bonte and Carla M.L. van Herpen. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.